AACR VIRTUAL PATIENT ADVOCATE FORUM: THE TRANSFORMATIVE POTENTIAL OF BIOMARKERS
Tuesday, August 23, 2022; 1 – 3:30 p.m. ET/ 10 a.m.- 12:30 p.m. PTRegister Today
Each person’s cancer has a unique pattern of biomarkers, making biomarker testing a critical part of diagnostics and treatment. This Forum will explore where and how biomarkers are changing cancer research and care to benefit patients with cancer.
Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine of USC, Los Angeles, California
Steven D. Averbuch, MD, S.D. Averbuch Consulting, LLC, Princeton, New Jersey
George D. Demetri, MD, FAACR, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
Jill Feldman, AACR Scientist↔Survivor Program®, EGFR Resisters, Chicago, Illinois
Joshua LaBaer, MD, PhD, Arizona State University, Biodesign Institute, Tempe, Arizona
Laura van ‘t Veer, PhD, UCSF Hellen Diller Family Comprehensive Cancer Center, San Francisco, CaliforniaProgram Agenda Speaker Bios
AACR Patient Advocate Forums
The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and health care communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public.